Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension

BACKGROUND: The evidence regarding triple oral combination therapy for patients with pulmonary arterial hypertension (PAH) is scarce. This study was performed to investigate the effectiveness and safety of triple oral combination therapy with macitentan, riociguat, and selexipag. METHODS: Among cons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Respir Dis
Main Authors: Momoi, Mizuki, Hiraide, Takahiro, Shinya, Yoshiki, Momota, Hiromi, Fukui, Shogo, Kawakami, Michiyuki, Itabashi, Yuji, Fukuda, Keiichi, Kataoka, Masaharu
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919213/
https://ncbi.nlm.nih.gov/pubmed/33627044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466621995048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados